EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Guanylation Reactions for the Rational Design of Cancer Therapeutic Agents

Almudena Del Campo-Balguerías iD, Blanca Parra-Cadenas iD, Cristina Nieto-Jimenez, Iván Bravo iD, Consuelo Ripoll, Elisa Poyatos-Racionero iD, Pawel Gancarski, Fernando Carrillo-Hermosilla iD, Carlos Alonso-Moreno iD, Alberto Ocaña iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241813820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Almudena Del Campo-Balguerías und 9 weiteren Autor:innen. Beteiligte Einrichtung: Unidad nanoDrug, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla-La Mancha, 02008 Albacete, Spain. Hauptthemen laut MEDLINE: Guanidines, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de ciencia e Innovación y Agencia Estatal de la Investigación, Junta de Comunidades de Castilla-La Mancha, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The modular synthesis of the guanidine core by guanylation reactions using commercially available ZnEt2 as a catalyst has been exploited as a tool for the rapid development of antitumoral guanidine candidates. Therefore, a series of phenyl-guanidines were straightforwardly obtained in very high yields. From the in vitro assessment of the antitumoral activity of such structurally diverse guanidines, the guanidine termed ACB3 has been identified as the lead compound of the series. Several biological assays, an estimation of AMDE values, and an uptake study using Fluorescence Lifetime Imaging Microscopy were conducted to gain insight into the mechanism of action. Cell death apoptosis, induction of cell cycle arrest, and reduction in cell adhesion and colony formation have been demonstrated for the lead compound in the series. In this work, and as a proof of concept, we discuss the potential of the catalytic guanylation reactions for high-throughput testing and the rational design of guanidine-based cancer therapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GuanidinesNeoplasmsHumansGuanidineApoptosisCell Death

Stichwörter der Autor:innen

breast cancerguanidinesguanylation reactionshigh-throughput testing

Substanzen

GuanidineGuanidines

Autor:innen und Institutionen

  • Unidad nanoDrug, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla-La Mancha, 02008 Albacete, Spain.
  • Departamento Química Inorgánica, Orgánica y Bioquímica, Facultad de Farmacia de Albacete-Centro de Innovación en Química Avanzada (ORFEO-CINQA), Universidad de Castilla-La Mancha, 02008 Albacete, Spain.
  • Departamento de Química Inorgánica, Orgánica y Bioquímica-Centro de Innovación en Química Avanzada (ORFEO-CINQA), Universidad de Castilla-La Mancha, 13071 Ciudad Real, Spain.
  • Experimental Therapeutics Unit, Hospital Clínico San Carlos, IdISSC, Fundación Jiménez Díaz, START, 28040 Madrid, Spain.
  • Departamento Química-Física, Facultad de Farmacia de Albacete, Universidad de Castilla-La Mancha, 02008 Albacete, Spain.
  • Cancerappy, Avda Ribera De Axpe, 28, 48950 Erandio, Spain.

ORCID-Profile: Almudena Del Campo-Balguerías, Blanca Parra-Cadenas, Iván Bravo, Elisa Poyatos-Racionero, Fernando Carrillo-Hermosilla, Carlos Alonso-Moreno, Alberto Ocaña

Förderung

  • Ministerio de ciencia e Innovación y Agencia Estatal de la Investigación
  • Junta de Comunidades de Castilla-La Mancha
  • Instituto de Salud Carlos III
  • JCCM

Zitieren

APA

Del Campo-Balguerías, A., Parra-Cadenas, B., Nieto-Jimenez, C., Bravo, I., Ripoll, C., Poyatos-Racionero, E., Gancarski, P., Carrillo-Hermosilla, F., Alonso-Moreno, C., & Ocaña, A. (2023). Guanylation Reactions for the Rational Design of Cancer Therapeutic Agents. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241813820

Vancouver

Del Campo-Balguerías A, Parra-Cadenas B, Nieto-Jimenez C, Bravo I, Ripoll C, Poyatos-Racionero E, et al. Guanylation Reactions for the Rational Design of Cancer Therapeutic Agents. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241813820

BibTeX
@article{DelCampoBalgueras2023,
  author = {Del Campo-Balguerías, Almudena and Parra-Cadenas, Blanca and Nieto-Jimenez, Cristina and Bravo, Iván and Ripoll, Consuelo and Poyatos-Racionero, Elisa and Gancarski, Pawel and Carrillo-Hermosilla, Fernando and Alonso-Moreno, Carlos and Ocaña, Alberto},
  title = {Guanylation Reactions for the Rational Design of Cancer Therapeutic Agents},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241813820}
}
Kostenlos starten →